Article
Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology Practice
2024-09-11
Abstract excerpt
<h4>Objectives</h4> To assess the utility of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay (Karius Test TM ; KT) in the evaluation of patients in an outpatient rheumatology practice. <h4>Methods</h4> All patients with a KT ordered and obtained by a rheumatology provider in the outpatient setting from 1 January 2020 through 31 December 2022 were retrospectively identified. Demographi...
Topics
Open a Topic to create a Post that cites this publication.
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Blood groups and transfusion
- Cancer Genomics and Diagnostics
- Hematological disorders and diagnostics
- Infective Endocarditis Diagnosis and Management
- Orthopaedic implants and arthroplasty
- Orthopedic Infections and Treatments
Identifiers and source
- Literature Corpus work
- a43a7e9f-3d87-5814-b0b8-2272665ee4c4
- DOI
- 10.1101/2024.09.09.24313356
